DEF 14A Filing

Company

Alzamend Neuro, Inc.

Filed

May 31, 2024

Period of Report

July 8, 2024

Accession Number

0001214659-24-010336

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →